Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.215 USD | -2.87% | -23.40% | +118.92% |
05-02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+118.92% | 148M | |
+22.69% | 46.4B | |
-1.18% | 41.75B | |
+48.20% | 41.37B | |
-3.52% | 29.71B | |
+10.61% | 26.01B | |
-19.56% | 19.52B | |
+30.86% | 12.43B | |
+0.07% | 12.18B | |
-0.67% | 12.13B |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- HC Wainwright Adjusts Price Target on Cardiff Oncology to $13 From $14, Maintains Buy Rating